Ccm Investment Advisers LLC Bristol Myers Squibb CO Transaction History

Ccm Investment Advisers LLC

$887 Million
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 05, 2024	SELL	$48.48 - $57.85 $8.68 Million - $10.4 Million	-179,014 Reduced 91.79%	16,009 $821,000
Q3 2023 Dec 08, 2023	BUY	$57.89 - $64.73 $271,967 - $304,101	4,698 Added 2.47%	195,023 $11.3 Million
Q2 2023 Aug 21, 2023	BUY	$63.71 - $70.74 $513,693 - $570,376	8,063 Added 4.42%	190,325 $12.2 Million
Q1 2023 May 17, 2023	BUY	$65.71 - $74.53 $1.9 Million - $2.15 Million	28,911 Added 18.85%	182,262 $12.6 Million
Q4 2022 Feb 15, 2023	SELL	$68.48 - $81.09 $703,837 - $833,443	-10,278 Reduced 6.28%	153,351 $11 Million
Q3 2022 Nov 09, 2022	SELL	$0.13 - $76.84 $703 - $415,934	-5,413 Reduced 3.2%	163,629 $11.6 Million
Q2 2022 Jul 27, 2022	SELL	$72.62 - $79.98 $139,793 - $153,961	-1,925 Reduced 1.13%	169,042 $13 Million
Q1 2022 May 03, 2022	BUY	$61.48 - $73.72 $882,483 - $1.06 Million	14,354 Added 9.17%	170,967 $12.5 Million
Q4 2021 Feb 01, 2022	SELL	$53.63 - $62.52 $2.39 Million - $2.79 Million	-44,608 Reduced 22.17%	156,613 $9.76 Million
Q3 2021 Oct 26, 2021	BUY	$59.17 - $69.31 $379,930 - $445,039	6,421 Added 3.3%	201,221 $11.9 Million
Q2 2021 Jul 30, 2021	BUY	$61.91 - $67.42 $1.82 Million - $1.98 Million	29,360 Added 17.75%	194,800 $13 Million
Q1 2021 May 07, 2021	BUY	$59.34 - $66.74 $494,836 - $556,544	8,339 Added 5.31%	165,440 $10.4 Million
Q4 2020 Feb 25, 2021	BUY	$57.74 - $65.43 $48,617 - $55,092	842 Added 0.54%	157,101 $9.75 Million
Q3 2020 Nov 10, 2020	BUY	$57.43 - $63.64 $23,374 - $25,901	407 Added 0.26%	156,259 $9.42 Million
Q2 2020 Aug 10, 2020	BUY	$54.82 - $64.09 $906,996 - $1.06 Million	16,545 Added 11.88%	155,852 $9.16 Million
Q1 2020 May 22, 2020	BUY	$46.4 - $67.43 $6.3 Million - $9.16 Million	135,807 Added 3880.2%	139,307 $7.76 Million
Q4 2019 Feb 20, 2020	BUY	$49.21 - $64.19 $172,235 - $224,665	3,500 New	3,500 $224,000
Q4 2018 Feb 12, 2019	SELL	$48.76 - $63.23 $180,168 - $233,634	-3,695 Closed	0 $0
Q3 2018 Nov 05, 2018	SELL	$55.19 - $62.25 $30,906 - $34,860	-560 Reduced 13.16%	3,695 $229,000
Q2 2018 Aug 13, 2018	SELL	$50.53 - $62.98 $26,022 - $32,434	-515 Reduced 10.8%	4,255 $235,000
Q1 2018 May 09, 2018	SELL	$59.92 - $68.98 $13,482 - $15,520	-225 Reduced 4.5%	4,770 $301,000
Q4 2017 Feb 22, 2018	SELL	$59.94 - $65.35 $36,863 - $40,190	-615 Reduced 10.96%	4,995 $306,000
Q3 2017 Nov 02, 2017	BUY	$55.23 - $63.74 $309,840 - $357,581	5,610	5,610 $357,000

Others Institutions Holding BMY

# of Institutions

2,533

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$11.1 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.34 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.47 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.59 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.59 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $125B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ccm Investment Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ccm Investment Advisers LLC with notifications on news.

Account